indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

Govt. Urgently Needs to Deploy “Auto Disable Syringes” to Limit HIV Epidemic: Rajiv Nath, AISNMA

admin
Saddened to hear about 46 people getting infected with HIV due to reuse of a single syringe, Mr. Rajiv Nath, President, All India Syringes and Needles Manufacturers Association (AISNMA) feels this could be just a tip of an iceberg as the problem is spread across the country. If this menace is not stopped, India could be staring at an HIV / AIDS epidemic, Mr. Nath said questioning National AIDS Control organization (NACO)’s lax attitude towards injection safety and preventable measures in its strategy to fight HIV. Mr. Rajiv Nath said, ‘UP’s healthcare is fragile. It needs urgent HSS and introduction of UIP including urgent deployment of Auto Disable syringes and needle stick prevention IV Cannula to immediately limit epidemic from spreading.’ “Is injection safety in public healthcare a key element in NACO’s strategy to fight HIV as is done in Africa?”, Mr. Nath asked. The answer obviously is no as it thinks spread of infection via public healthcare is not an issue and therefore India has no funding or monitoring policy dedicated to public healthcare system strengthening . Further, there is no tracking of infections or registry via public healthcare from reuse of syringes/needles or needle stick injuries. “NACO is myopic in limiting problem of Syringe reuse to only drug users”, Mr Nath said. Every time such tragedies like current one in Unnao  or earlier in Modasa in Gujarat happens, it causes discussions and publication of a Guideline book and then forgotten. Bad habits can't be changed by education alone if culturally engrained and therefore reliance has to be on technology. As a car alarm forces you to belt up so does Auto Disable (AD) Syringes ensure- no possibility of Reuse. Quoting WHO, Mr. Nath said that “Every $ 1 spent on injection safety saves $ 14 in public healthcare. A recent Health Technology Assessment study released by DHR finds Reuse Prevention AD Syringes cost effective at 1.90 Rs. Why use disposables that get misused and reused to become carrier of infection without universal precautions?” As in immunization, AD syringes can be used universally for all therapeutic injections. In this context, it is important to ask, what is India’s Road Map to switch to Auto Disable Syringes as per WHO advisory to achieve this by 2020? Uganda and Tanzania banned imports and use of Std Disposable syringes to fight HIV and to disallow access to Quacks and Private sector to Disposable Syringes. Why it is not being done in India?, Mr Nath implored further. The Ministers in various states of Health and Family Welfare and DGHS asks us to stop making Disposable Syringes and switch to AD syringes. We are ready to do so, but India should first stop buying disposable syringes in a predictable planned phased manner and switch to AD syringes and then CDSCO/ Regulators need to enforce a ban/ restricted access. With more than 40 thousands Quacks in Delhi alone one can imagine how quickly and fiercely the HIV epidemic is spreading. Reusing syringes constitutes one of their main unsafe practices.  Therefore 46 people infected with HIV in Unnao of Uttar Pradesh could as well be news of any part of Delhi and anywhere from rest of India. “It is high time Govt. takes immediate cognizance of the serious issue and deploy Auto Disable Syringes to save India from Threat of HIV / AIDS epidemic. It is MUST for India to enforce Injection Safety on priority basis” concluded Mr Nath.

Recommended

Dr Nilesh G Satbhai joins Nanavati Max as Director of Plastic, Reconstructive Microsurgery & Hand Transplantation

OneSource Pharma registers Rs 3,758 M revenue in Q2FY26

Biocon posts Rs 4,296 Cr revenue at Q2FY26

NHA renews MoU with DHR and ICMR

Granules Life Sciences receives US FDA approval for Hyderabad facility

Cipla, Natco, Hetero and Annora Win Key Generic Drug Supply Contracts in China

Dementia India Alliance and Apollo AyurVAID Hospitals sign MoU

Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions